Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
In the liver, insulin controls both lipid and glucose metabolism through its cell surface receptor and intracellular mediators such as phosphatidylinositol 3-kinase and serine-threonine kinase AKT. The insulin signaling pathway is further modulated by protein tyrosine phosphatase or lipid phosphatase. Here, we investigated the function of phosphatase and tension homologue deleted on chromosome 10 (PTEN), a negative regulator of the phosphatidylinositol 3-kinase/AKT pathway, by targeted deletion of Pten in murine liver. Deletion of Pten in the liver resulted in increased fatty acid synthesis, accompanied by hepatomegaly and fatty liver phenotype. Interestingly, Pten liver-specific deletion causes enhanced liver insulin action with improved systemic glucose tolerance. Thus, deletion of Pten in the liver may provide a valuable model that permits the study of the metabolic actions of insulin signaling in the liver, and PTEN may be a promising target for therapeutic intervention for type 2 diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, mice deficient in methionine adenosyltransferase 1A (MAT1A) (224), phosphatase and tensin homolog (PTEN) (225), or alternative oxidase (AOX) (226) spontaneously exhibit pathological features of MASH.”
From Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH) (2023) · cites this paper as [225]
Citations
Cites
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244
Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity
Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J.-I., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0255 · Cited by 4,856
Cloning of adiponectin receptors that mediate antidiabetic metabolic effects
Yamauchi, T., Kamon, J., Ito, Y., Tsuchida, A., Yokomizo, T., Kita, S., Sugiyama, T., Miyagishi, M., Hara, K., Tsunoda, M., et al. (2003) · Nature · doi:10.1038/nature01705 · Cited by 3,176
Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN
Stambolic, V., Suzuki, A., de la Pompa, J. L., Brothers, G. M., Mirtsos, C., Sasaki, T., Ruland, J., Penninger, J. M., Siderovski, D. P., & Mak, T. W. (1998) · Cell · doi:10.1016/s0092-8674(00)81780-8 · Cited by 2,551
Role of Brain Insulin Receptor in Control of Body Weight and Reproduction
Brüning, J. C., Gautam, D., Burks, D. J., Gillette, J., Schubert, M., Orban, P. C., Klein, R., Krone, W., Müller-Wieland, D., & Kahn, C. R. (2000) · Science · doi:10.1126/science.289.5487.2122 · Cited by 2,235
Elchebly, M., Payette, P., Michaliszyn, E., Cromlish, W., Collins, S., Loy, A. L., Normandin, D., Cheng, A., Himms-Hagen, J., Chan, C.-C., et al. (1999) · Science · doi:10.1126/science.283.5407.1544 · Cited by 2,210
Cho, H., Mu, J., Kim, J. K., Thorvaldsen, J. L., Chu, Q., Crenshaw, E. B., Kaestner, K. H., Bartolomei, M. S., Shulman, G. I., & Birnbaum, M. J. (2001) · Science · doi:10.1126/science.292.5522.1728 · Cited by 1,836
Pten is essential for embryonic development and tumour suppression
Cristofano, A. D., Pesce, B., Cordon-Cardo, C., & Pandolfi, P. P. (1998) · Nature Genetics · doi:10.1038/1235 · Cited by 1,516
Michael, M. D., Kulkarni, R. N., Postic, C., Previs, S. F., Shulman, G. I., Magnuson, M. A., & Kahn, C. R. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00015-8 · Cited by 1,296
Self-citationAdipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver
Abel, E. D., Peroni, O., Kim, J. K., Kim, Y.-B., Boss, O., Hadro, E., Minnemann, T., Shulman, G. I., & Kahn, B. B. (2001) · Nature · doi:10.1038/35055575 · Cited by 1,253
Self-citation
Research works printed but not linked: 6
- Lee, W. N., Bassilian, S., Guo, Z., Schoeller, D., Edmond, J., Bergner, E. A. & Byerley, L. O. (1994) Am. J. Physiol. 266, E372-E383.8166257
- Asante-Appiah, E. & Kennedy, B. P. (2003) Am. J. Physiol. 284, E663-E670.
- Matsubara, M., Katayose, S. & Maruoka, S. (2003) Eur. J. Endocrinol. 148, 343-350.12611616
- Chanussot, F., Ulmer, M., Ratanasavanh, R., Max, J. P. & Debry, G. (1984) Int. J. Obes. 8, 259-270.6378817
- 10.1172/JCI15001 · doi:10.1172/jci15001 · Paper page
- Carvalheira, J. B., Ribeiro, E. B., Folli, F., Velloso, L. A. & Saad, M. J. (2003) Biol. Chem. Hoppe-Seyler 384, 151-159.
Cited by
Insulin Receptor Signaling in Normal and Insulin-Resistant States
Boucher, J., Kleinridders, A., & Kahn, C. R. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009191 · Cited by 1,473
“Muscle, adipose tissue, or liver-specific deletion of PTEN in mice increases insulin sensitivity (Stiles et al. 2004; Kurlawalla-Martinez et al. 2005; Wijesekara et al. 2005), and mice with whole-body PTEN haploinsufficiency show improved glucose tolerance and increased insulin sensitivity (Wong et al.”
BackgroundMichelotti, G. A., Machado, M. V., & Diehl, A. M. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.183 · Cited by 974
The PTEN–PI3K pathway: of feedbacks and cross-talks
Carracedo, A., & Pandolfi, P. P. (2008) · Oncogene · doi:10.1038/onc.2008.247 · Cited by 878
“As an example, Pten-deleted muscle, liver or fat tissue exhibits increased glucose sensitivity (Stiles et al., 2004; Kurlawalla-Martinez et al., 2005; Wijesekara et al., 2005).”
BackgroundTan, Y., Zhang, Z., Zheng, C., Wintergerst, K. A., Keller, B. B., & Cai, L. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0339-2 · Cited by 835
Metabolic Syndrome and Insulin Resistance: Underlying Causes and Modification by Exercise Training
Roberts, C. K., Hevener, A. L., & Barnard, R. J. (2013) · Comprehensive Physiology · doi:10.1002/cphy.c110062 · Cited by 831
Metadata
- Authors
- Stiles, B., Wang, Y., Stahl, A., Bassilian, S., Lee, W. P., Kim, Y.-J., Sherwin, R., Devaskar, S., Lesche, R., Magnuson, M. A., & Wu, H.
- Affiliations
- Palo Alto Medical Foundation (US)
- Departments of Molecular and Medical Pharmacology and Howard Hughes Medical Institute and Department of Pediatrics Neonatology and Developmental Biology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095; Research Institute, Palo Alto Medical Foundation and Stanford School of Medicine, Palo Alto, CA 94301; Department of Pediatrics, Harbor-UCLA Medical Center, Los Angeles, CA 90502; Department of Internal Medicine, Yale University School of Medicine, New Haven, CT...
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2004-02-09
- Volume
- 101
- Issue
- 7
- Pages
- 2082-2087
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC357055
- OpenAlex
- W2003295985
- Cited by
- 436
- References
- 50
- Citations by year
- 2026: 10 · 2025: 24 · 2024: 12 · 2023: 18 · 2022: 21 · 2021: 23 · 2020: 16 · 2019: 15 · 2018: 19 · 2017: 21 · 2016: 18 · 2015: 33 · 2014: 23 · 2013: 27 · 2012: 24
- FWCI
- 6.51
- Type
- journal article
- Language
- en
- Update notices
- correction (2004-04-06)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Defense
- Howard Hughes Medical Institute
- National Institutes of Health (DK56339)
- National Cancer Institute (CA-98-013)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-56339, P30DK056339)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- PTEN, liver-specific gene deletion, hepatic fatty acid synthesis, hepatic steatosis, insulin sensitivity, insulin signaling, PI3K/Akt signaling, glucose tolerance, hepatomegaly, type 2 diabetes, protein tyrosine phosphatase
- MeSH terms
- Adipose Tissue, Animals, Blood Glucose, Fasting, Fatty Acids, Fatty Liver, Gluconeogenesis, Glucose Tolerance Test, Glycogen, Hepatomegaly, Insulin, Insulin Resistance, Liver, Organ Specificity, RNA, Messenger, Gene Deletion, Hepatocytes, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity. https://app.cochat.ai/papers/10.1073/pnas.0308617100
- The paper
- Stiles, B., Wang, Y., Stahl, A., Bassilian, S., Lee, W. P., Kim, Y.-J., Sherwin, R., Devaskar, S., Lesche, R., Magnuson, M. A., & Wu, H. (2004). Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.0308617100
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.